Editor: Akhmetova Aigerim
Translator: Bolysbek Dana
Author: Tursunova Balkadisha
In medical practice, “gender dysphoria” is described as a feeling of mismatch between one's biological sex and gender identity, and is also characterized by a mental disorder that leads to depression and anxiety. Hormones are biologically active substances that regulate the balance between organs, playing an important role in the metabolism and physiological development of the whole organism. In turn, the National Health Service recommended taking drugs that stop the release and production of sex hormones for teenagers with gender dysphoria.
The proposal to use hormones was made by the Gender Identity Development Service (Gids), based in London and Leeds, to delay adolescents' time to understand their gender. This therapy is called cross-sex hormonal therapy, which involves taking estrogen or testosterone only for people over 16 years of age.
However, a lawsuit was filed against the Gender Identity Clinic by the UK Health Service as there were good reasons. As a result of taking hormones, many adolescents have experienced side effects. The National Institute for Health and Care Excellence (NICE) cites the reduction in bone density as a possible side effect of triptorelin, the puberty-blocking drug used by Gids.
This situation was resolved by the fact that both sides agreed on the use of drugs for those adolescents who have already fully formed the physiological restructuring of the body and taking hormonal drugs will not give serious and irreversible consequences. And also if therapy is prescribed only by those specialists who work specifically on the problems of sexual development.
Source: https://www.bbc.com/news/health-51034461
